Summary
Background. The growth of both cancer cells and fetal tissue is rapid; however, cancer cells de-differentiate and proliferate in a disorderly manner, whereas fetal tissues differentiate and proliferate in an orderly manner. Thus, there may be both common and different factors that are involved in the process of the uncontrolled cell growth of pancreatic cancers and the development of the fetal pancreas. The common part of the mechanisms should be in the regulation of the cell cycle, resulting in rapid proliferation via such mechanisms as growth stimulation and avoidance of apoptosis. Therefore, in the current study we investigated the expression of apoptosis-related proteins in fetal pancreatic tissues.
Methods. Sixteen human embryonic and fetal pancreatic tissues obtained between 6 and 32 wk of gestation were used. We immunohistochemically examined the protein expression of Bcl-2, Bcl-XL, Mcl-1, and Bax. Further, the expression of insulin, glucagon, and proliferting cell nuclear antigen (PCNA), and TdT-mediated dUTP-biotin nick-end labeling (TUNEL) staining were examined.
Results. In embryonic and fetal pancreatic tissues, Bcl-2 was not detected in any type of pancreatic cell (acinar, ductal, or islet). Bcl-XL was expressed in all types of pancreatic cells throughout the gestation. Mcl-1 was expressed in all types of pancreatic components, and strongly expressed in the margin of the islets. Bax, a pro-apoptotic protein, was expressed in all components. PCNA was strongly expressed in the embryonic and fetal pancreas, especially in early stages of gestation; however, TUNEL staining was negative in all samples. At least one antiapoptotic protein was expressed in all types of pancreatic cells.
Conclusion. The results of the current study indicate that active proliferation and avoidance of apoptosis take place in embryonic and fetal pancreatic tissues, which may be controlled by particular combinations of apoptosis-related proteins. Among these proteins, Bcl-XL and Mcl-1 may play an important role in the proliferation and differentiation of the embryonic and fetal pancreas.
Similar content being viewed by others
References
Pour PM. Cell differentiation during pancreatic carcinogenesis. Scand J Gastroenterol Suppl 1988; 151: 123–130.
Bagshawe KD, Noble MI. Cardio-respiratory aspects of trophoblastic tumours. Q J Med 1966; 35: 39–54.
Luz NP, Crottogini JJ, Negrete VS. A method for identification of chorionic villi in peripheral blood of pregnant women. Am J Obstet Gynecol 1966; 94: 1079–1084.
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619.
Boise LH, Gonzalez Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608.
Hanada M, Aime Sempe C, Sato T, Reed JC. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 1995; 270: 11,962–11,969.
Dietrich JB. Apoptosis and anti-apoptosis genes in the Bcl-2 family. Arch Physiol Biochem 1997; 105: 125–135.
Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994; 54: 6348–6352.
Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 1997; 89: 630–643.
Bubendorf L, Sauter G, Moch H, Jordan P, Blochlinger A, Gasser TC, Mihatsch MJ. Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol 1996; 148: 1557–1565.
Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422–2427.
Krajewska M, Fenoglio Preiser CM, Krajewski S, Song K, Macdonald JS, Stemmerman G, Reed JC. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 1996; 149: 1449–1457.
Binder C, Marx D, Overhoff R, Binder L, Schauer A, Hiddemann W. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Ann Oncol 1995; 6: 1005–1010.
Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, Fujimoto K, et al. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 1999; 56: 73–82.
Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501.
Doi R, Wada M, Hosotani R, Lee JU, Koshiba T, Fujimoto K, et al. Role of Apoptosis in Duct Obstruction-Induced Pancreatic Involution in Rats. Pancreas 1997; 14: 39–46.
Mezquita B, Mezquita C, Mezquita J. Marked differences between avian and mammalian testicular cells in the heat shock induction and polyadenylation of Hsp70 and ubiquitin transcripts. FEBS Lett 1998; 436: 382–386.
Dubois PM. Ontogeny of the endocrine pancreas. Horm Res 1989; 32: 53–60.
Hahn von Dorsche H, Falt K, Titlbach M, Reiher H, Hahn HJ, Falkmer S. Immunohistochemical, morphometric, and ultrastructural investigations of the early development of insulin, somatostatin, glucagon, and PP cells in foetal human pancreas. Diabetes Res 1989; 12: 51–56.
Mally MI, Otonkoski T, Lopez AD, Hayek A. Developmental gene expression in the human fetal pancreas. Pediatr Res 1994; 36: 537–544.
Bouwens L. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas. Microsc Res Tech 1998; 43: 332–336.
Lu QL, Poulsom R, Wong L, Hanby AM. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993; 169: 431–437.
LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142: 743–753.
Lichnovsky V, Kolar P. Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos. J Clin Pathol 1998; 51: 131–137.
Wada M, Doi R, Hosotani R, Lee JU, Fujimoto K, Koshiba T, Miyamoto Y, Fukuoka S, Imamura M. Expression of Bcl-2 and PCNA in duct cells after pancreatic duct ligation in rats. Pancreas 1997; 15: 176–182.
Gonzalez Garcia M, Garcia I, Ding L, O’Shea S, Boise LH, Thompson CB, Nunez G. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 1995; 92: 4304–4308.
Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998; 279: 300–307.
Celis JE, Madsen P, Celis A, Nielsen HV, Gesser B. Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division. FEBS Lett 1987; 220: 1–7.
Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989; 9: 57–66.
McEvoy RC, Madson KL. Pancreatic insulin-, glucagon-, and somatostatin-positive islet cell populatins during the perinatal development of the rat. I. Morphometric quantitation. Biol Neonate 1980; 38: 248–254.
Rutter WJ. The development of the endocrine and exocrine pancreas. Monogr Pathol 1980; 21: 30–38.
Bouwens L, Lu WG, De Krijger R. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997; 40: 398–404.
Bouwens L, Wang RN, De Blay E, Pipeleers DG, Kloppel G. Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kobayashi, H., Doi, R., Hosotani, R. et al. Immunohistochemical analysis of apoptosis-related proteins in human embryonic and fetal pancreatic tissues. International Journal of Pancreatology 27, 113–122 (2000). https://doi.org/10.1385/IJGC:27:2:113
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/IJGC:27:2:113